Theron Odlaug

Theron Odlaug

Director/Board Member chez Wahl Clipper Corp.

75 ans
Health Technology
Commercial Services
Finance

Profil

Dr. Theron (Ted) Odlaug brings over 40 years of experience with significant leadership roles in the pharmaceutical industry.
Ted is an advisor to Signet and has worked with several Signet portfolio companies over the last 14 plus years.
Ted is currently a Board Member of Signet portfolio companies Ascendia Pharmaceuticals Inc. and Pharma Nobis, LLC.
He is also President of the Board of the Dravet Syndrome Foundation.
He was a Board Member of CoreRx Inc. until the 2021 sale to NovaQuest.
Prior he was Executive Chairman of Impopharma Inc. and CEO of leon-nanodrugs GmbH, and a member of its Supervisory Board.
He was the Executive Chairman of Cedarburg Pharmaceuticals until the company was sold to Albany Molecular Research Inc. in 2014.
From 2011 Ted was the Executive Chairman and CEO of Planet Biopharmaceuticals until the company was sold to Ares Life Sciences in 2014.
From 2008 until 2011, he was President and CEO of CyDex Pharmaceuticals, Inc. at which time the company was sold to Ligand Pharmaceuticals, Inc. Prior to that, he was Executive Vice President and a member of the senior management committee at Fujisawa Healthcare Inc. until its merger with Yamanouchi in 2005, which resulted in the formation of Astellas Pharma.
He left Astellas in 2006 after successfully supporting the U.S.
post-merger integration process.
Earlier in his career he had senior positions at Bayer AG and Baxter.
Ted holds Bachelor's and Master's degrees from the University of Missouri at Kansas City and a Ph.D.
in Public Health from the University of Minnesota.

Postes actifs de Theron Odlaug

SociétésPosteDébut
Director/Board Member 01/01/1999
Dravet Syndrome Foundation, Inc. Director/Board Member 01/01/2019
Director/Board Member 01/01/2021
Consultant / Advisor 01/01/2015
Curyx Partners Hong Kong Ltd. Consultant / Advisor 01/05/2021
Consultant / Advisor 01/01/2017
Tous les postes actifs de Theron Odlaug

Anciens postes connus de Theron Odlaug

SociétésPosteFin
TLGY ACQUISITION CORPORATION President 19/04/2023
Director/Board Member 01/01/2021
Chief Executive Officer 10/01/2017
░░░░░░░░ ░░░░░░ ░░░░ ░░░░░ ░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░░░░░ ░░░░ ░░░░░ ░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░
Voir l'expérience en détail de Theron Odlaug

Formation de Theron Odlaug

University of Missouri Graduate Degree
University of Minnesota Doctorate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Theron Odlaug

Relations

44

Relations au 1er degré

28

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées4
BAXTER INTERNATIONAL INC.

Health Technology

BAYER AG

Health Technology

WAVERLEY PHARMA INC.

Health Technology

TLGY ACQUISITION CORPORATION

Finance

Entreprise privées22

Health Technology

Health Technology

Finance

Health Technology

Health Technology

Producer Manufacturing

Health Technology

Health Technology

Health Technology

Health Technology

Fujisawa Healthcare, Inc.

Antigen Laboratories, Inc.

Health Technology

Commercial Services

EIR Healthcare Advisors LLC

Health Technology

Commercial Services

Commercial Services

Health Technology

Health Technology

Mylan API US LLC

Dravet Syndrome Foundation, Inc.

Curyx Partners Hong Kong Ltd.

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Theron Odlaug